Publication
Avaliação do risco oncológico : avaliação da viabilidade de um seguro/cobertura específica
| Summary: | Oncologic disease is nowadays one of the main causes of death in Portugal, and certainly one of the situations with the greatest impact at the level of hospital care and morbidity. With the treatment costs rising, and the increased incidence of some types of cancer, many people doubt the possibility of public institutuions support both nancially and physically all the needs they will have to face in the near future. Moreover, although there are currently some a ordable health insurances, it has been observed that in case of cancer patients, the available capital is rapidly depleted. This work is part of an Industrial PhD project and its main goal is to assess the costs for Multicare of covering cancer diseases expenses in a specic and broader way than it has been done in portuguese insurance market. To this end, as a preliminary task, we analyse the company usual pricing method and, when possible, in an optimized way. Subsequently, the calculation and implementation of the specific cost cost model for the actuarial risk involved in cancer diseases was developed, both in an annual renewal insurance and long-term insurance perspectives. |
|---|---|
| Main Authors: | Ferreira, Marli Andreia Monteiro de Amorim, 1988- |
| Subject: | Teses de doutoramento - 2018 |
| Year: | 2018 |
| Country: | Portugal |
| Document type: | doctoral thesis |
| Access type: | restricted access |
| Associated institution: | Universidade de Lisboa |
| Language: | Portuguese |
| Origin: | Repositório da Universidade de Lisboa |
| Summary: | Oncologic disease is nowadays one of the main causes of death in Portugal, and certainly one of the situations with the greatest impact at the level of hospital care and morbidity. With the treatment costs rising, and the increased incidence of some types of cancer, many people doubt the possibility of public institutuions support both nancially and physically all the needs they will have to face in the near future. Moreover, although there are currently some a ordable health insurances, it has been observed that in case of cancer patients, the available capital is rapidly depleted. This work is part of an Industrial PhD project and its main goal is to assess the costs for Multicare of covering cancer diseases expenses in a specic and broader way than it has been done in portuguese insurance market. To this end, as a preliminary task, we analyse the company usual pricing method and, when possible, in an optimized way. Subsequently, the calculation and implementation of the specific cost cost model for the actuarial risk involved in cancer diseases was developed, both in an annual renewal insurance and long-term insurance perspectives. |
|---|